Eyemax
Payments companies reported to CMS as associated with Eyemax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Eyemax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Eyemax
These are the largest totals companies reported as associated with Eyemax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Muhammad Hasan | Orlando, FL | Gastroenterology (Internal Medicine) | $3,089.18 |
| Stuart Amateau | Minneapolis, MN | Gastroenterology (Internal Medicine) | $514.90 |
| Andrew Storm | Winston Salem, NC | Gastroenterology (Internal Medicine) | $500.00 |
| Tolga Erim | Weston, FL | Internal Medicine | $264.74 |
| Alexander Schlachterman | Philadelphia, PA | Gastroenterology (Internal Medicine) | $257.81 |
| Daniel Hogan | Asheville, NC | Gastroenterology (Internal Medicine) | $238.98 |
| Herman Suga | Chicago, IL | Gastroenterology (Internal Medicine) | $238.98 |
| Amitabh Chak | Cleveland, OH | Gastroenterology (Internal Medicine) | $237.76 |
| Peter Draganov | Gainesville, FL | Gastroenterology (Internal Medicine) | $222.05 |
| Ahmed Ibrahem Ahmed Swi | Columbia, MO | Gastroenterology (Internal Medicine) | $204.08 |
Prescribed Eyemax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.